Nonencephalopathic Psychiatric Manifestations (NEPM) and Response to Niacin in Pellagra: A Scoping Review

Downloads

Published

2022-10-31

DOI:

https://doi.org/10.55229/ijbs.v25i2.08

Keywords:

pellagra, psychiatric manifestations, kynurenine, niacin, serotonin, tryptophan

Dimensions Badge

Issue

Vol. 25 No. 02 (2022): Indian Journal of Behavioural Sciences

Section

REVIEW ARTICLE

License

Copyright (c) 2022 Roshan Sutar, Devendra S. Basera, Ashish Pakhre, Pooja Chaudhary, Anuja Lahiri

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

You are free to:

  • The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Crossref
Scopus
Google Scholar
Europe PMC

Authors

  • Roshan Sutar Department of Psychiatry, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
  • Devendra S. Basera Department of Psychiatry, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
  • Ashish Pakhre Department of Psychiatry, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
  • Pooja Chaudhary Department of Psychiatry, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
  • Anuja Lahiri Department of Community and Family Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India

Abstract

Psychiatric manifestations of pellagra could be subtle but important to recognize in clinical practice. These may vary from non-syndromic symptoms of anxiety, depression, and psychosis to pellagrous encephalopathy. The course and outcome of pellagra’s non-encephalopathic psychiatric manifestations (NEPM) are variable and have not received much attention. Therefore, a review in this regard is deemed necessary to understand the evolution of psychiatric symptoms and possible neurochemical changes produced in pellagra. A focused scoping review of the literature using Preferred Reporting Items for Systematic reviews and Meta-Analyses- extension for Scoping Reviews (PRISMA-ScR) guidelines was carried out to chart the results of studies to find out the characteristic nature of NEPM, role of niacin, and underlying etiopathogenesis. The review included 12 studies comprising 271 participants. Depressive and insomnia symptoms were the most frequent manifestations of NEPM followed by anxiety, thought disorder, psychomotor agitation, hallucinations, confusion, and disorientation. Alcohol use remains the most common cause of NEPM in pellagra, followed by nutritional deficiency. The alteration in the kynurenine pathway is a probable mechanism implicated in the NEPM of pellagra and future research should explore the role of niacin replacement in such patients. The findings of the review incite further discussion and research on biomarkers for patients with pellagra and subtype of patients with depression who share a common immune-inflammatory pathway.

How to Cite

Sutar, R., Basera, D. S., Pakhre, A., Chaudhary, P., & Lahiri, A. (2022). Nonencephalopathic Psychiatric Manifestations (NEPM) and Response to Niacin in Pellagra: A Scoping Review. Indian Journal of Behavioural Sciences, 25(02), 128–142. https://doi.org/10.55229/ijbs.v25i2.08

Downloads

Download data is not yet available.

References

Krishnaswamy K, Murthy PSVR. Mental changes and platelet serotonin in pellagrins. Clin Chim Acta. 1970;27(2):301-304. doi:10.1016/0009-8981(70)90348-7

López M, Olivares JM, Berrios GE. Pellagra encephalopathy in the context of alcoholism: Review and case report. Alcohol Alcohol. 2014;49(1):38-41. doi:10.1093/alcalc/agt070

Sharma B, Sannegowda RB, Jain R, Dubey P, Prakash S. A rare case of alcoholic pellagra encephalopathy with startle myoclonus and marked response to niacin therapy: time for a new dictum? BMJ Case Rep. Published online 2013. doi:10.1136/bcr-2013-008906

Park SH, Na DL, Lee JH, et al. Alcoholic pellagra encephalopathy combined with Wernicke disease. J Korean Med Sci. 1991;6(1):87-93. doi:10.3346/jkms.1991.6.1.87

Park K, Oeda T, Sawada H. A case of alcoholic pellagra encephalopathy presenting with spinal myoclonus. Neurol Clin Pract. 2015;5(6):472-474. doi:10.1212/CPJ.0000000000000165

Oldham MA, Ivkovic A. Pellagrous encephalopathy presenting as alcohol withdrawal delirium: A case series and literature review. Addict Sci Clin Pract. Published online 2012. doi:10.1186/1940-0640-7-12

Terada N, Kinoshita K, Taguchi S, Tokuda Y. Wernicke encephalopathy and pellagra in an alcoholic and malnourished patient. 2015;2015:bcr2015209412. Accessed February 8, 2022. https://casereports.bmj.com/content/2015/bcr-2015-209412

Slooter AJC, Otte WM, Devlin JW, et al. Updated nomenclature of delirium and acute encephalopathy: statement of ten Societies. Intensive Care Med 2020 465. 2020;46(5):1020-1022. doi:10.1007/S00134-019-05907-4

Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med. 2018;169(7):467-473. doi:10.7326/M18-0850

Pitsavas S, Andreou C, Bascialla F, Bozikas VP, Karavatos A. Pellagra encephalopathy following B-complex vitamin treatment without niacin. Int J Psychiatry Med. 2004;34(1):91-95. doi:10.2190/29XV-1GG1-U17K-RGJH

Delgado-Sanchez L, Godkar D, Niranjan S. Pellagra: Rekindling of an old flame. Am J Ther. 2008;15(2):173-175. doi:10.1097/MJT.0b013e31815ae309

Prakash R, Gandotra S, Singh LK, Das B, Lakra A. Rapid resolution of delusional parasitosis in pellagra with niacin augmentation therapy. Gen Hosp Psychiatry. 2008;30(6):581-584. doi:10.1016/j.genhosppsych.2008.04.011

Luthe SK, Sato R. Alcoholic Pellagra as a Cause of Altered Mental Status in the Emergency Department. J Emerg Med. 2017;53(4):554-557. doi:10.1016/j.jemermed.2017.05.008

Filgueiras F de M, Stolarczuk D de A, Gripp AC, Succi ICB. Lipomatose simétrica benigna e pelagra, associadas ao alcoolismo. An Bras Dermatol. 2011;86(6):1189-1192. doi:10.1590/S0365-05962011000600021

Suwalka BM, Rohatagi S. International Journal of Medical Science and Education An official Publication of Association for Scientific and Medical Education (ASME) PELLAGRA ASSOCIATED WITH PSYCHIATRIC ILLNESSES IN VAGHAD AND ARAVALI HILL AREAS NEAR UDAIPUR. Int.j.med.sci.educ. 5(1):112-116. Accessed February 8, 2022. www.ijmse.comwww.ijmse.com

Krishnaswamy K. Plasma “cortisol” levels in pellagrins. Clin Chim Acta. 1971;34(3):415-418. doi:10.1016/0009-8981(71)90094-5

Raghuram TC, Krishnaswamy K. Serotonin Metabolism in Pellagra. Arch Neurol. 1975;32(10):708-710. doi:10.1001/archneur.1975.00490520078015

Wang W, Liang B. Case report of mental disorder induced by niacin deficiency. Shanghai Arch psychiatry. 2012;24(6):352-354. doi:10.3969/J.ISSN.1002-0829.2012.06.008

Amanullah S, Seeber C. Niacin deficiency resulting in neuropsychiatry symptoms: a case study and review of literature. Clin Neuropsychiatry. Published online February 1, 2010:10-15. Accessed February 9, 2022. https://go.gale.com/ps/i.do?p=HRCA&sw=w&issn=17244935&v=2.1&it=r&id=GALE%7CA228121874&sid=googleScholar&linkaccess=fulltext

Ishii N, Nishihara Y. Pellagra encephalopathy among tuberculous patients: Its relation to isoniazid therapy. J Neurol Neurosurg Psychiatry. 1985;48(7):628-634. doi:10.1136/jnnp.48.7.628

Serdaru M, Hausser-hauw C, Laplane D, et al. THE CLINICAL SPECTRUM OF ALCOHOLIC PELLAGRA ENCEPHALOPATHYA RETROSPECTIVE ANALYSIS OF 22 CASES STUDIED PATHOLOGICALLY. Brain. 1988;111(4):829-842. doi:10.1093/BRAIN/111.4.829

Wallengren J, Thelin I. Pellagra-like skin lesions associated with Wernicke’s encephalopathy in a heavy wine drinker [11]. Acta Derm Venereol. 2002;82(2):152-154. doi:10.1080/00015550252948301/

Kobayashi Z, Tsuchiya K, Takahashi M, et al. Morel’s laminar sclerosis showing apraxia of speech: Distribution of cortical lesions in an autopsy case. Neuropathology. 2010;30(1):76-83. doi:10.1111/J.1440-1789.2009.01039.X

Kapas I, Majtenyi K, Törö K, Keller E, Voigtländer T, Kovacs GG. Pellagra encephalopathy as a differential diagnosis for Creutzfeldt-Jakob disease. Metab Brain Dis 2012 272. 2012;27(2):231-235. doi:10.1007/S11011-012-9308-8

Chidlovskii E, Tahar A, Deschasse G, Couturier P. Encéphalopathie de Gayet Wernicke associée à une encéphalopathie pellagrique : complication rare et inhabituelle chez une femme âgée hospitalisée pour pneumopathie d’inhalation. La Rev Médecine Interne. 2012;33(8):453-456. doi:10.1016/J.REVMED.2012.05.010

Savvidou S. Pellagra: A Non-Eradicated Old Disease. Clin Pract 2014, Vol 4, Page 637. 2014;4(1):637. doi:10.4081/CP.2014.637

Narasimha VL, Ganesh S, Reddy S, et al. Pellagra and Alcohol Dependence Syndrome: Findings From a Tertiary Care Addiction Treatment Centre in India. Alcohol Alcohol. 2019;54(2):148-151. doi:10.1093/ALCALC/AGZ004

Acute encephalopathy due to coexistent nicotinic acid and thiamine deficiency - PubMed. Accessed April 19, 2022. https://pubmed.ncbi.nlm.nih.gov/8117565/

Swash M, Roberts AH, Murnaghan DJ. Reversible pellagra-like encephalopathy with ethionamide and cycloserine. Tubercle. 1972;53(2):132-136. doi:10.1016/0041-3879(72)90030-X

[A suspected case of alcoholic pellagra encephalopathy with marked response to niacin showing myoclonus and ataxia as chief complaints] - PubMed. Accessed April 19, 2022. https://pubmed.ncbi.nlm.nih.gov/16519110/

Koga M, Shimono M, Tateishi J, Ikuta F. Chronic Alcoholism: Report of an Autopsy Case and Comparison With Pseudoulegyric Type of Hepatocerebral Degeneration. Psychiatry Clin Neurosci. 1978;32(1):141-148. doi:10.1111/J.1440-1819.1978.TB02788.X

Badawy AAB. Pellagra and alcoholism: A biochemical perspective. Alcohol Alcohol. 2014;49(3):238-250. doi:10.1093/alcalc/agu010

Kertesz SG. Pellagra in 2 homeless men. Mayo Clin Proc. 2001;76(3):315-318. doi:10.4065/76.3.315

Li R, Yu K, Wang Q, Wang L, Mao J, Qian J. Pellagra Secondary to Medication and Alcoholism. Nutr Clin Pract. 2016;31(6):785-789. doi:10.1177/0884533616660991

Lu JY, Yu CL, Wu MZ. Pellagra in an immunocompetent patient with cytomegalovirus colitis [14]. Am J Gastroenterol. 2001;96(3):932-934. doi:10.1016/S0002-9270(00)02452-7

Dean J, Keshavan M. The neurobiology of depression: An integrated view. Asian J Psychiatr. 2017;27:101-111. doi:10.1016/J.AJP.2017.01.025

Steiner J, Bogerts B, Sarnyai Z, et al. Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired bloodbrain barrier integrity. World J Biol Psychiatry. Published online 2012. doi:10.3109/15622975.2011.583941

Bay-Richter C, Linderholm KR, Lim CK, et al. A role for inflammatory metabolites as modulators of the glutamate N-methyl-d-aspartate receptor in depression and suicidality. Brain Behav Immun. Published online 2015. doi:10.1016/j.bbi.2014.07.012

Müller N, Schwarz MJ. The immune-mediated alteration of serotonin and glutamate: Towards an integrated view of depression. Mol Psychiatry. Published online 2007. doi:10.1038/sj.mp.4002006

Brousse G, Arnaud B, Vorspan F, et al. Alteration of glutamate/GABA balance during acute alcohol withdrawal in emergency department: A prospective analysis. Alcohol Alcohol. Published online 2012. doi:10.1093/alcalc/ags078

Gabrynowicz JW, Dumbrill M. A clinical trial of leptazole with nicotinic acid in the management of psycho-geriatric patients. Med J Aust. 1968;1(19):799-802. doi:10.5694/j.1326-5377.1968.tb28911.x

Chouinard G, Young SN, Annable L, Sourkes TL. TRYPTOPHAN-NICOTINAMIDE COMBINATION IN DEPRESSION. Lancet. 1977;309(8005):249. doi:10.1016/S0140-6736(77)91036-4

Dickerson JWT, Wiryanti* J. Pellagra and mental disturbance. Proc Nutr Soc. 1978;37(2):167-171. doi:10.1079/PNS19780021

Hui S, Heng L, Shaodong W, Fangyu W, Zhenkai W. Pellagra affecting a patient with Crohn’s disease. An Bras Dermatol. 2017;92(6):879. doi:10.1590/ABD1806-4841.20174461